Cell Talk Translating research discoveries to commercialised cell and gene therapy products; asking the right questions as an academic. When translating research discoveries in the cell and gene therapy sector, numerous considerations must be…Cell TherapiesNovember 28, 2023
News Arovella Therapeutics partners with Cell Therapies to develop its ALA-101 manufacturing process for cancer clinical trials Cell Therapies Pty Ltd is partnering with Arovella Therapeutics (ASX: ALA) to develop the manufacturing…Cell TherapiesNovember 8, 2023
Cell Talk From Concept to Commercialisation: Why the selection of an organisation for a cell and gene therapies can impact your patient outcomes and competitive advantage The development pipeline of cell and gene therapies faces numerous obstacles while striving for the…Cell TherapiesAugust 14, 2023
News Cell Therapies Pty Ltd is delighted to announce the appointment of Dr Bev Menner as the company’s new Chief Executive Officer. Cell Therapies Pty Ltd, a leading provider of cell and gene therapy products in the…Cell TherapiesJuly 26, 2023
News New commercial-scale cell and gene therapy manufacturing facility for APAC market supply Cell Therapies Pty Ltd. is excited to announce the opening of new cell and gene…Cell TherapiesJuly 25, 2023
Cell Talk Translating innovative cell therapies: What is GMP? The cell therapy sector is growing rapidly and within it, cell-based therapies derived from human…Cell TherapiesMay 22, 2023
Cell Talk Why Australia should be your choice for CGT development The development of cell and gene therapy is rapidly growing in our industry with a…Cell TherapiesFebruary 22, 2023
News Cell Therapies to manufacture BioNTech’s product candidate BNT211 in Australia Cell Therapies Pty Ltd (CTPL) has been engaged by Germany-based biopharmaceutical company BioNTech SE (BioNTech)…Cell TherapiesSeptember 21, 2022
News Cell Therapies Joins Australia’s Cell & Gene Catalyst Steering Group We are delighted to be part of the Steering Group to lead Australia’s Cell and…Cell TherapiesAugust 3, 2022
News Carina Biotech partners with Cell Therapies to deliver a first-in-human CAR-T cell therapy trial to treat colorectal patients Cell Therapies is partnering with Carina Biotech, a leading Australian immuno-oncology company, to manufacture their…Cell TherapiesMay 31, 2022